- Home
- FBIOP vs PSA Comparison
FBIOP vs PSA Comparison
Compare FBIOP & PSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBIOP
- PSA
- Stock Information
- Founded
- FBIOP N/A
- PSA 1972
- Country
- FBIOP United States
- PSA United States
- Employees
- FBIOP 101
- PSA N/A
- Industry
- FBIOP Biotechnology: Pharmaceutical Preparations
- PSA Real Estate Investment Trusts
- Sector
- FBIOP Health Care
- PSA Real Estate
- Exchange
- FBIOP Nasdaq
- PSA Nasdaq
- Market Cap
- FBIOP N/A
- PSA N/A
- IPO Year
- FBIOP N/A
- PSA N/A
- Fundamental
- Price
- FBIOP $6.74
- PSA $293.79
- Analyst Decision
- FBIOP
- PSA Buy
- Analyst Count
- FBIOP 0
- PSA 11
- Target Price
- FBIOP N/A
- PSA $339.64
- AVG Volume (30 Days)
- FBIOP N/A
- PSA 935.9K
- Earning Date
- FBIOP N/A
- PSA 04-30-2025
- Dividend Yield
- FBIOP N/A
- PSA 4.08%
- EPS Growth
- FBIOP N/A
- PSA N/A
- EPS
- FBIOP N/A
- PSA 10.64
- Revenue
- FBIOP N/A
- PSA $4,715,437,000.00
- Revenue This Year
- FBIOP N/A
- PSA $1.22
- Revenue Next Year
- FBIOP N/A
- PSA $3.92
- P/E Ratio
- FBIOP N/A
- PSA $27.61
- Revenue Growth
- FBIOP N/A
- PSA 3.74
- 52 Week Low
- FBIOP N/A
- PSA $256.31
- 52 Week High
- FBIOP N/A
- PSA $369.99
- Technical
- Relative Strength Index (RSI)
- FBIOP 67.87
- PSA 51.78
- Support Level
- FBIOP $6.00
- PSA $284.09
- Resistance Level
- FBIOP $6.80
- PSA $300.50
- Average True Range (ATR)
- FBIOP 0.42
- PSA 11.00
- MACD
- FBIOP 0.16
- PSA 1.77
- Stochastic Oscillator
- FBIOP 96.19
- PSA 84.72
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.